Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02004028
What this trial is testing

Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants

Who this might be right for
Malignant Pleural Mesothelioma
Verastem, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00634205
What this trial is testing

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Lung Cancer Working Party 45
Testing effectiveness (Phase 2)UnknownNCT02497053
What this trial is testing

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 70
Testing effectiveness (Phase 2)Study completedNCT02592551
What this trial is testing

MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Baylor College of Medicine 24
Large-scale testing (Phase 3)Ended earlyNCT01907100
What this trial is testing

Nintedanib (BIBF 1120) in Mesothelioma

Who this might be right for
Mesothelioma
Boehringer Ingelheim 545
Testing effectiveness (Phase 2)Study completedNCT00251550
What this trial is testing

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesotherioma
Eli Lilly and Company 12
Testing effectiveness (Phase 2)Ended earlyNCT01861301
What this trial is testing

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Epithelioid MesotheliomaRecurrent Malignant MesotheliomaSarcomatoid Mesothelioma+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00025207
What this trial is testing

Gefitinib in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282873
What this trial is testing

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor MalignanciesMalignant Mesothelioma (MM)
TYK Medicines, Inc 219
Testing effectiveness (Phase 2)Study completedNCT03048474
What this trial is testing

Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Large-scale testing (Phase 3)Study completedNCT00651456
What this trial is testing

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 448
Testing effectiveness (Phase 2)Study completedNCT04480372
What this trial is testing

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Who this might be right for
Malignant Pleural MesotheliomaNon-small Cell Lung Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)Study completedNCT02397928
What this trial is testing

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

Who this might be right for
Malignant Pleural Mesothelioma
NovoCure Ltd. 82
Testing effectiveness (Phase 2)Study completedNCT00513877
What this trial is testing

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Cancer Trials Ireland 33
Testing effectiveness (Phase 2)Ended earlyNCT00281125
What this trial is testing

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer and Pleural Mesothelioma
Nevada Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT02436733
What this trial is testing

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 64
Next Page